Genetic study of proteins is a breakthrough in drug development for complex diseases
Monday, September 7, 2020 - 10:11
in Biology & Nature
An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol, has demonstrated how genetic data can be used to support drug target prioritization by identifying the causal effects of proteins on diseases.